Excellent outcomes reported for first targeted therapy for pediatric Hodgkin lymphoma
(St. Jude Children's Research Hospital) Results from a collaborative multi-site clinical trial show the success of adding brentuximab vedotin, reducing radiation.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Children | Clinical Trials | Hospitals | Lymphoma | Pediatrics